Technical analysis of ADMA Biologics, Inc. (ADMA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally.
Price Performance
| 1 month | +9.40% |
| 3 months | +9.94% |
| Year-to-date | -39.36% |
| 1 year | -24.40% |
| 3 years | +203.01% |
| 5 years | +713.24% |
| 10 years | +120.76% |
52-Week Range
| 52-week High | $20.46 |
| 52-week Low | $7.21 |
| Avg Volume (90d) | 2.7M |
Technical Indicators
| SMA 50 | $10.02 |
| SMA 200 | $10.93 |
| Beta | 0.82 |
| 30-day Volatility (annualised) | 39.8% |
| Price vs SMA 50 | +10.3% |
| Price vs SMA 200 | +1.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $18.24 | |
| 2026-01 | $17.30 | -5.2% |
| 2026-02 | $15.57 | -10.0% |
| 2026-03 | $9.01 | -42.1% |
| 2026-04 | $10.25 | +13.8% |
| 2026-05 | $7.98 | -22.1% |
| 2026-06 | $8.37 | +4.9% |
| 2026-07 | $8.46 | +1.1% |
| 2026-08 | $9.39 | +11.0% |
| 2026-09 | $10.03 | +6.8% |
| 2026-10 | $11.41 | +13.8% |
| 2026-11 | $11.06 | -3.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $0.20 | $138M |
| 2026-08-05 | $0.16 | $125M |
| 2026-05-06 | $0.19 | $140M |
| 2026-02-25 | $0.18 | $140M |
| 2025-11-05 | $0.16 | $140M |
| 2025-08-06 | $0.14 | $130M |
| 2025-05-07 | $0.16 | $122M |
Price
| Price | $11.11 (closing price, November 3, 2026) |
| Market Cap | $2.5B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 15.87 |
| Price / Book | 6.21 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.50 |
| Current Ratio | 6.97 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 19.98 |